In my hospital theÂ surgeons decided to take an active role in the PICC program, which previous to this development had been the exclusive territory of IV therapy.Â At my hospital I was shocked to see the relationship between our IV team and a certain vendor that controls most of the PICC market. ItÂ was very unprofessional, if not a total violation of medical ethics.Â We had Rn's working for this company doing classes and yet making decisions about our PICC program. When ever I asked for objective data all I got was a regurgitation of a set response that our IV Rn's got from one of the companies paid Rn's. Many of my fellow surgeons have been reprimanded because of their "close" relationships toÂ the orthopedic companies and this practice has been curtailed. If my hospital is any indication of what is going on with not all, but many IV teams, then the FDA needs to take a serious look at this completeÂ breach of medicalÂ ethics. The surgeons were able to put a stop to this at our hospital, but inÂ reading many of the posts on this forum, I can see too many of you are in bed with vendors.